Anion exchange HPLC isolation of High-Density Lipoprotein (HDL) and on-line estimation of proinflammatory HDL

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Ji, Xiang ^a,b   Xu, Hao ^b,d   Zhang, Hao ^b,d   Hillery, Cheryl A ^b,c,d   Gao, Hai Qing ^a,b   Pritchard Jr , Kirkwood A ^b,d  

^a SHANDONG UNIVERSITY   (China)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c BLOOD RESEARCH INSTITUTE   (United States)

^d Children's Hospital of Wisconsin   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; XANTHINE OXIDASE; ANION EXCHANGE RESIN; AUTACOID; CHOLESTEROL; XANTHINE;

ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME RELEASE; HEMOGLOBIN BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISOLATION PROCEDURE; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MOUSE; NONHUMAN; ONLINE ANALYSIS; OXIDATION KINETICS; PRECIPITATION; PURIFICATION; QUANTITATIVE ANALYSIS; SICKLE CELL ANEMIA; ANIMAL; BLOOD; C57BL MOUSE; CASE CONTROL STUDY; CELL FREE SYSTEM; CHEMISTRY; ION EXCHANGE CHROMATOGRAPHY; ISOLATION AND PURIFICATION; METABOLISM; ONLINE SYSTEM; OXIDATION REDUCTION REACTION; PROCEDURES; STANDARD;

ANEMIA, SICKLE CELL; ANIMALS; ANION EXCHANGE RESINS; CASE-CONTROL STUDIES; CELL-FREE SYSTEM; CHOLESTEROL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, ION EXCHANGE; HEMOGLOBINS; HUMANS; INFLAMMATION MEDIATORS; LIPOPROTEINS, HDL; MICE, INBRED C57BL; ONLINE SYSTEMS; OXIDATION-REDUCTION; REFERENCE STANDARDS; TRIGLYCERIDES; XANTHINE; XANTHINE OXIDASE;

EID: 84897390408     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091089     Document Type: Article

References (38)

1. Assmann G, von Eckardstein A, Funke H (1993) High density lipoproteins, reverse transport of cholesterol, and coronary artery disease. Insights from mutations. Circulation 87: III28-34. (Pubitemid 23097055)
2. Navab M, Fogelman AM, Berliner JA, Territo MC, Demer LL, et al. (1995) Pathogenesis of atherosclerosis. Am J Cardiol 76: 18C-23C.
3. Gharavi NM, Gargalovic PS, Chang I, Araujo JA, Clark MJ, et al. (2007) High-density lipoprotein modulates oxidized phospholipid signaling in human endothelial cells from proinflammatory to anti-inflammatory. Arterioscler Thromb Vasc Biol 27: 1346-1353. (Pubitemid 46809424)
4. deGoma EM, deGoma RL, Rader DJ (2008) Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches. J Am Coll Cardiol 51: 2199-2211. (Pubitemid 351754991)
5. Khera AV, Cuchel M, de la Llera-Moya M, Rodrigues A, Burke MF, et al. (2011) Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med 364: 127-135.
6. Kuvin JT, Ramet ME, Patel AR, Pandian NG, Mendelsohn ME, et al. (2002) A novel mechanism for the beneficial vascular effects of high-density lipoprotein cholesterol: enhanced vasorelaxation and increased endothelial nitric oxide synthase expression. Am Heart J 144: 165-172. (Pubitemid 34734771)
7. Mastorikou M, Mackness M, Mackness B (2006) Defective metabolism of oxidized phospholipid by HDL from people with type 2 diabetes. Diabetes 55: 3099-3103. (Pubitemid 44923648)
8. Van Lenten BJ, Wagner AC, Nayak DP, Hama S, Navab M, et al. (2001) High-density lipoprotein loses its anti-inflammatory properties during acute influenza a infection. Circulation 103: 2283-2288. (Pubitemid 32433719)
9. Woo JM, Lin Z, Navab M, Van Dyck C, Trejo-Lopez Y, et al. (2010) Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis. Arthritis Res Ther 12: R93.
10. Weihrauch D, Xu H, Shi Y, Wang J, Brien J, et al. (2007) Effects of D-4F on vasodilation, oxidative stress, angiostatin, myocardial inflammation and angiogenic potential in Tight-skin mice. Am J Physiol Heart Circ Physiol 293: H1432-1441. (Pubitemid 47367186)
11. Yuditskaya S, Tumblin A, Hoehn GT, Wang G, Drake SK, et al. (2009) Proteomic identification of altered apolipoprotein patterns in pulmonary hypertension and vasculopathy of sickle cell disease. Blood 113: 1122-1128.
12. Ansell BJ, Navab M, Hama S, Kamranpour N, Fonarow G, et al. (2003) Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment. Circulation 108: 2751-2756. (Pubitemid 37498976)
13. Van Lenten BJ, Hama SY, de Beer FC, Stafforini DM, McIntyre TM, et al. (1995) Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest 96: 2758-2767.
14. Navab M, Hama SY, Hough GP, Subbanagounder G, Reddy ST, et al. (2001) A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids. J Lipid Res 42: 1308-1317. (Pubitemid 32744255)
15. Frei AC, Guo Y, Jones DW, Pritchard KA Jr., Fagan KA, et al. (2008) Vascular dysfunction in a murine model of severe hemolysis. Blood 112: 398-405.
16. Pritchard KA Jr., Ou J, Ou Z, Shi Y, Franciosi JP, et al. (2004) Hypoxia-induced acute lung injury in murine models of sickle cell disease. Am J Physiol Lung Cell Mol Physiol 286: L705-714. (Pubitemid 38365054)
17. Wood KC, Hsu LL, Gladwin MT (2008) Sickle cell disease vasculopathy: a state of nitric oxide resistance. Free Radic Biol Med 44: 1506-1528.
18. Sadrzadeh SM, Graf E, Panter SS, Hallaway PE, Eaton JW (1984) Hemoglobin. A biologic fenton reagent. J Biol Chem 259: 14354-14356. (Pubitemid 15222248)
19. Hillery CA, Du MC, Wang WC, Scott JP (2000) Hydroxyurea therapy decreases the in vitro adhesion of sickle erythrocytes to thrombospondin and laminin. Br J Haematol 109: 322-327. (Pubitemid 30350711)
20. Hirowatari Y, Yoshida H, Kurosawa H, Doumitu KI, Tada N (2003) Measurement of cholesterol of major serum lipoprotein classes by anion-exchange HPLC with perchlorate ion-containing eluent. J Lipid Res 44: 1404-1412. (Pubitemid 37279623)
21. Hatefi Y, Hanstein WG (1969) Solubilization of particulate proteins and nonelectrolytes by chaotropic agents. Proc Natl Acad Sci U S A 62: 1129-1136.
22. Itskovitz HD, Flamenbaum W, De Gaetano C, Pritchard KA Jr., Stemerman MB (1989) Effect of lovastatin on serum lipids in patients with nonfamilial primary hypercholesterolemia. Clin Ther 11: 862-872. (Pubitemid 20028319)
23. Hanson MS, Xu H, Flewelen TC, Holzhauer SL, Retherford D, et al. (2012) A Novel Hemoglobin-Binding Peptide Reduces Cell-Free Hemoglobin in Murine Hemolytic Anemia. Am J Physiol Heart Circ Physiol.
24. Xu H, Wang J, Ou J, Jones DW, Oldham KT, et al. (2006) Reciprocal binding of xanthine oxidase and myeloperoxidase with apoA-I correlates with HDL anti- and pro-inflammatory properties. The FASEB Journal 20: A198-A199.
25. Ou J, Wang J, Xu H, Ou Z, Sorci-Thomas MG, et al. (2005) Effects of D-4F on vasodilation and vessel wall thickness in hypercholesterolemic LDL receptor-null and LDL receptor/apolipoprotein A-I double-knockout mice on Western diet. Circ Res 97: 1190-1197.
26. Aslan M, Ryan TM, Adler B, Townes TM, Parks DA, et al. (2001) Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease. Proc Natl Acad Sci U S A 98: 15215-15220. (Pubitemid 34013994)
27. Reynolds GD, St Clair RW (1985) A comparative microscopic and biochemical study of the uptake of fluorescent and 125I-labeled lipoproteins by skin fibroblasts, smooth muscle cells, and peritoneal macrophages in culture. Am J Pathol 121: 200-211. (Pubitemid 16230688)
28. Chuang PT, Cheng HJ, Lin SJ, Jan KM, Lee MM, et al. (1990) Macromolecular transport across arterial and venous endothelium in rats. Studies with Evans blue-albumin and horseradish peroxidase. Arteriosclerosis 10: 188-197. (Pubitemid 20103580)
29. Vincent SH, Grady RW, Shaklai N, Snider JM, Muller-Eberhard U (1988) The influence of heme-binding proteins in heme-catalyzed oxidations. Arch Biochem Biophys 265: 539-550.
30. Tolkacheva NV, Levachev MM, Medvedev FA, Kulakova SN, Mazurets AF (1989) [Transport of fatty acids and products of their peroxidation by serum albumin in ischemic and non-coronary injury of the myocardium]. Vopr Med Khim 35: 89-92.
31. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR (1977) High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 62: 707-714. (Pubitemid 8110784)
32. Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, et al. (1998) Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 279: 1615-1622. (Pubitemid 28248586)
33. Gurfinkel EP, de la Fuente RL, Mendiz O, Mautner B (2002) Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Study. Circulation 105: 2143-2147. (Pubitemid 34517156)
34. Tillett HE, Smith JW, Gooch CD (1983) Excess deaths attributable to influenza in England and Wales: age at death and certified cause. Int J Epidemiol 12: 344-352. (Pubitemid 13001919)
35. Navab M, Hama SY, Cooke CJ, Anantharamaiah GM, Chaddha M, et al. (2000) Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1. J Lipid Res 41: 1481-1494.
36. Navab M, Hama SY, Anantharamaiah GM, Hassan K, Hough GP, et al. (2000) Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3. J Lipid Res 41: 1495-1508.
37. Vaisar T, Pennathur S, Green PS, Gharib SA, Hoofnagle AN, et al. (2007) Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. J Clin Invest 117: 746-756. (Pubitemid 46348533)
38. Zorn U, Haug C, Celik E, Wennauer R, Schmid-Kotsas A, et al. (2001) Characterization of modified low density lipoprotein subfractions by capillary isotachophoresis. Electrophoresis 22: 1143-1149. (Pubitemid 32409385)